Full Text View
Tabular View
No Study Results Posted
Related Studies
Mazindol for Cocaine Abuse - 2
This study has been completed.
Study NCT00000277   Information provided by National Institute on Drug Abuse (NIDA)
First Received: September 20, 1999   Last Updated: June 23, 2005   History of Changes

September 20, 1999
June 23, 2005
 
  • Side effects
  • Drug use
  • Retention
Same as current
Complete list of historical versions of study NCT00000277 on ClinicalTrials.gov Archive Site
 
 
 
Mazindol for Cocaine Abuse - 2
Mazindol for Cocaine Abuse

The purpose of this study is to evaluate high and low dose mazindol for cocaine abuse.

 
Phase II
Interventional
Treatment
Cocaine-Related Disorders
Drug: Mazindol
 
 

*   Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.
 
Completed
0
 
 

Please contact site for information.

Both
18 Years and older
No
Contact information is only displayed when the study is recruiting subjects
United States
 
 
NCT00000277
 
P50-09250-2
National Institute on Drug Abuse (NIDA)
VA Connecticut Healthcare System
Principal Investigator: Thomas R Kosten, M.D. VA Connecticut Healthcare System
National Institute on Drug Abuse (NIDA)
December 2002

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP